Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
Daudi (human Burkitt's lymphoma) whole cell lysate (non-denatured)
LNCaP clone FGC (human prostate carcinoma) whole cell lysate (non-denatured)
THP-1 (human acute monocytic leukemia) whole cell lysate (non-denatured)
K-562 (human chronic myelogenous leukemia) whole cell lysate (non-denatured)
MOLT-4 (human acute lymphoblastic leukemia, T cell) whole cell lysate (non-denatured)
PC-12 (rat adrenal gland pheochromocytoma) whole cell lysate (non-denatured)
HeLa (human cervical epithelioid carcinoma) whole cell lysate (non-denatured)
HL-60 (human promyelocytic leukemia) whole cell lysate (non-denatured)
A-431 (human epidermoid carcinoma) whole cell lysate (non-denatured)